Dr. Adoo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10320 W Mcdowell Rd Bldg H 8025
Avondale, AZ 85392Phone+1 623-238-7330
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 1995 - 1998
St Agnes HealthCareResidency, Internal Medicine, 1992 - 1995
University of Ghana Medical SchoolClass of 1990
Certifications & Licensure
AZ State Medical License 2002 - 2026
MD State Medical License 1994 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2012
Clinical Trials
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer Start of enrollment: 2013 Mar 25
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsAn open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.Jeffrey L. Vacirca, Arlene Chan, Klára Mezei, Clarence S. Adoo, Zsuzsanna Pápai
Cancer Medicine. 2018-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
